Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMM2N4T)

Drug Name
1607004-34-1 Drug Info
Synonyms ADAMTS Inhibitor C7; SCHEMBL15692551; CHEMBL3980860; BDBM194644; 1607004-34-1; US9206139, 3
Cross-matching ID
PubChem CID
74221072
TTD Drug ID
DMM2N4T

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Discontinued Drug(s)
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Aggrecanase-1 (ADAMTS4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9206139, 4 DM3NE8J N. A. N. A. Patented [1]
US9206139, 5 DMB4JS7 N. A. N. A. Patented [1]
SC-44463 DMBPNKT N. A. N. A. Terminated [2]
MMI270 DM38N2K Discovery agent N.A. Investigative [3]
(R)-2-(biphenyl-4-sulfonylamino)-propionic acid DM16JFS Discovery agent N.A. Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Aggrecanase-1 (ADAMTS4) TTYG6BU ATS4_HUMAN Inhibitor [1]

References

1 Aggrecanase inhibitors. US9206139.
2 Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivati... J Med Chem. 2001 Oct 11;44(21):3347-50.
3 Synthesis and biological evaluation of biphenylsulfonamide carboxylate aggrecanase-1 inhibitors. Bioorg Med Chem Lett. 2006 Jan 15;16(2):311-6.